ArticleEuropean journal of drug metabolism and pharmacokinetics2024

Mass Balance and Metabolic Pathways of Eliapixant, a P2X3 Receptor Antagonist, in Healthy Male Volunteers.

Stefanie Reif et al.PubMed ↗Publisher ↗

No numbers read from the abstract.